Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guo-Ping Yang

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Chemical Science|November 21, 2024
Three in one: engineering MOF channels <i>via</i> coordinated water arrays for regulated separation of alkanes and alkenesLu-Lu Ma, Pavel N Zolotarev, Kang Zhou, et al.
Acta Pharmacologica Sinica|September 27, 2016
Influences of CYP2D6<sup>*</sup>10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysisQi Pei, Lu Huang, Jie Huang, et al.
Zhonghua Nei Ke Za Zhi|May 24, 2011
[A multi-center, randomized, controlled, double blind and double dummy clinical trial of antofloxacin hydrochloride tablet versus levofloxacin tablet for the treatment of acute bacterial infections]Yong-hong Xiao, Hong Cui, Feng Xue, et al.
European Journal of Clinical Pharmacology|February 27, 2010
Effects of Ginkgo biloba extracts on diazepam metabolism: a pharmacokinetic study in healthy Chinese male subjectsXiao-Cong Zuo, Bi-Kui Zhang, Su-Jie Jia, et al.
Drug Metabolism and Pharmacokinetics|February 14, 2014
ABCB1 polymorphism and gender affect the pharmacokinetics of amlodipine in Chinese patients with essential hypertension: a population analysisXiao-cong Zuo, Wen-li Zhang, Hong Yuan, et al.
Plos One|October 21, 2014
Evaluation of the highly variable agomelatine pharmacokinetics in Chinese healthy subjects to support bioequivalence studyQi Pei, Yan Wang, Zhe-Yi Hu, et al.
Clinical and Experimental Pharmacology & Physiology|February 16, 2017
Impact of polymorphisms in angiogenesis-related genes on clinical outcomes of radiotherapy in patients with nasopharyngeal carcinomaWan-Le Ma, Rong Liu, Li-Hua Huang, et al.
European Journal of Clinical Pharmacology|May 12, 2018
Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese populationQi Pei, Jun-Yan Liu, Ji-Ye Yin, et al.
European Journal of Clinical Pharmacology|August 3, 2021
External evaluation of published population pharmacokinetic models of polymyxin BYa-Qian Li, Kai-Feng Chen, Jun-Jie Ding, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 19, 2017
Effects of genetic variants in UGT1A1, SLCO1B3, ABCB1, ABCC2, ABCG2, ORM1 on PK/PD of telmisartan in Chinese patients with mild to moderate essential hypertension
Qi Pei, Liu Yang, Hong-Yi Tan, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Chemical Science|November 21, 2024
Three in one: engineering MOF channels <i>via</i> coordinated water arrays for regulated separation of alkanes and alkenesLu-Lu Ma, Pavel N Zolotarev, Kang Zhou, et al.
Acta Pharmacologica Sinica|September 27, 2016
Influences of CYP2D6<sup>*</sup>10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysisQi Pei, Lu Huang, Jie Huang, et al.
Zhonghua Nei Ke Za Zhi|May 24, 2011
[A multi-center, randomized, controlled, double blind and double dummy clinical trial of antofloxacin hydrochloride tablet versus levofloxacin tablet for the treatment of acute bacterial infections]Yong-hong Xiao, Hong Cui, Feng Xue, et al.
European Journal of Clinical Pharmacology|February 27, 2010
Effects of Ginkgo biloba extracts on diazepam metabolism: a pharmacokinetic study in healthy Chinese male subjectsXiao-Cong Zuo, Bi-Kui Zhang, Su-Jie Jia, et al.
Drug Metabolism and Pharmacokinetics|February 14, 2014
ABCB1 polymorphism and gender affect the pharmacokinetics of amlodipine in Chinese patients with essential hypertension: a population analysisXiao-cong Zuo, Wen-li Zhang, Hong Yuan, et al.
Plos One|October 21, 2014
Evaluation of the highly variable agomelatine pharmacokinetics in Chinese healthy subjects to support bioequivalence studyQi Pei, Yan Wang, Zhe-Yi Hu, et al.
Clinical and Experimental Pharmacology & Physiology|February 16, 2017
Impact of polymorphisms in angiogenesis-related genes on clinical outcomes of radiotherapy in patients with nasopharyngeal carcinomaWan-Le Ma, Rong Liu, Li-Hua Huang, et al.
European Journal of Clinical Pharmacology|May 12, 2018
Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese populationQi Pei, Jun-Yan Liu, Ji-Ye Yin, et al.
European Journal of Clinical Pharmacology|August 3, 2021
External evaluation of published population pharmacokinetic models of polymyxin BYa-Qian Li, Kai-Feng Chen, Jun-Jie Ding, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 19, 2017
Effects of genetic variants in UGT1A1, SLCO1B3, ABCB1, ABCC2, ABCG2, ORM1 on PK/PD of telmisartan in Chinese patients with mild to moderate essential hypertension
Qi Pei, Liu Yang, Hong-Yi Tan, et al.
Pageof 14